These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 7947489)
1. Expression of type II transforming growth factor-beta receptor mRNA in human skin, as revealed by in situ hybridization. Matsuura H; Myokai F; Arata J; Noji S; Taniguchi S J Dermatol Sci; 1994 Aug; 8(1):25-32. PubMed ID: 7947489 [TBL] [Abstract][Full Text] [Related]
2. Ultraviolet irradiation alters transforming growth factor beta/smad pathway in human skin in vivo. Quan T; He T; Kang S; Voorhees JJ; Fisher GJ J Invest Dermatol; 2002 Aug; 119(2):499-506. PubMed ID: 12190876 [TBL] [Abstract][Full Text] [Related]
3. Downregulation of TGFbeta isoforms and their receptors contributes to keratinocyte hyperproliferation in psoriasis vulgaris. Doi H; Shibata MA; Kiyokane K; Otsuki Y J Dermatol Sci; 2003 Oct; 33(1):7-16. PubMed ID: 14527734 [TBL] [Abstract][Full Text] [Related]
4. Down-regulation of transforming growth factor-beta receptors I and II is seen in lesional but not non-lesional psoriatic epidermis. Leivo T; Leivo I; Kariniemi AL; Keski-Oja J; Virtanen I Br J Dermatol; 1998 Jan; 138(1):57-62. PubMed ID: 9536223 [TBL] [Abstract][Full Text] [Related]
5. In situ analysis of transforming growth factor-beta s (TGF-beta 1, TGF-beta 2, TGF-beta 3), and TGF-beta type II receptor expression in malignant melanoma. Schmid P; Itin P; Rufli T Carcinogenesis; 1995 Jul; 16(7):1499-503. PubMed ID: 7614683 [TBL] [Abstract][Full Text] [Related]
6. Reduced expression of mRNA for transforming growth factor beta (TGF beta) and TGF beta receptors I and II and decreased TGF beta binding to the receptors in in vitro-aged fibroblasts. Mori Y; Hatamochi A; Arakawa M; Ueki H Arch Dermatol Res; 1998 Mar; 290(3):158-62. PubMed ID: 9558492 [TBL] [Abstract][Full Text] [Related]
7. Connective tissue growth factor: expression in human skin in vivo and inhibition by ultraviolet irradiation. Quan T; He T; Kang S; Voorhees JJ; Fisher GJ J Invest Dermatol; 2002 Mar; 118(3):402-8. PubMed ID: 11874477 [TBL] [Abstract][Full Text] [Related]
8. Effect of healing on the expression of transforming growth factor beta(s) and their receptors in chronic venous leg ulcers. Cowin AJ; Hatzirodos N; Holding CA; Dunaiski V; Harries RH; Rayner TE; Fitridge R; Cooter RD; Schultz GS; Belford DA J Invest Dermatol; 2001 Nov; 117(5):1282-9. PubMed ID: 11710945 [TBL] [Abstract][Full Text] [Related]
9. Enhanced expression of transforming growth factor-beta s and transforming growth factor-beta type II receptor in the synovial tissues of patients with rheumatoid arthritis. Taketazu F; Kato M; Gobl A; Ichijo H; ten Dijke P; Itoh J; Kyogoku M; Rönnelid J; Miyazono K; Heldin CH Lab Invest; 1994 May; 70(5):620-30. PubMed ID: 8196359 [TBL] [Abstract][Full Text] [Related]
10. A "traffic control" role for TGFbeta3: orchestrating dermal and epidermal cell motility during wound healing. Bandyopadhyay B; Fan J; Guan S; Li Y; Chen M; Woodley DT; Li W J Cell Biol; 2006 Mar; 172(7):1093-105. PubMed ID: 16549496 [TBL] [Abstract][Full Text] [Related]
11. In situ analysis of transforming growth factors-beta (TGF-beta 1, TGF-beta 2, TGF-beta 3) and TGF-beta type II receptor expression in basal cell carcinomas. Schmid P; Itin P; Rufli T Br J Dermatol; 1996 Jun; 134(6):1044-51. PubMed ID: 8763422 [TBL] [Abstract][Full Text] [Related]
14. Differential regulation of transforming growth factor-beta receptors type I and II by platelet-derived growth factor in human dermal fibroblasts. Czuwara-Ladykowska J; Gore EA; Shegogue DA; Smith EA; Trojanowska M Br J Dermatol; 2001 Oct; 145(4):569-75. PubMed ID: 11703282 [TBL] [Abstract][Full Text] [Related]
15. Soluble transforming growth factor-beta type II receptor inhibits negative remodeling, fibroblast transdifferentiation, and intimal lesion formation but not endothelial growth. Smith JD; Bryant SR; Couper LL; Vary CP; Gotwals PJ; Koteliansky VE; Lindner V Circ Res; 1999 May; 84(10):1212-22. PubMed ID: 10347096 [TBL] [Abstract][Full Text] [Related]
16. Altered expression of keratinocyte growth factor and its receptor in psoriasis. Finch PW; Murphy F; Cardinale I; Krueger JG Am J Pathol; 1997 Dec; 151(6):1619-28. PubMed ID: 9403712 [TBL] [Abstract][Full Text] [Related]
17. Putative hyaluronan synthase mRNA are expressed in mouse skin and TGF-beta upregulates their expression in cultured human skin cells. Sugiyama Y; Shimada A; Sayo T; Sakai S; Inoue S J Invest Dermatol; 1998 Feb; 110(2):116-21. PubMed ID: 9457904 [TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-beta 1 localization in normal and psoriatic epidermal keratinocytes in situ. Kane CJ; Knapp AM; Mansbridge JN; Hanawalt PC J Cell Physiol; 1990 Jul; 144(1):144-50. PubMed ID: 1694857 [TBL] [Abstract][Full Text] [Related]
19. Perturbation of epidermal barrier function correlates with initiation of cytokine cascade in human skin. Nickoloff BJ; Naidu Y J Am Acad Dermatol; 1994 Apr; 30(4):535-46. PubMed ID: 7512582 [TBL] [Abstract][Full Text] [Related]
20. Downregulation of SMAD2, 4 and 6 mRNA and TGFbeta receptor I mRNA in lesional and non-lesional psoriatic skin. Yu H; Mrowietz U; Seifert O Acta Derm Venereol; 2009; 89(4):351-6. PubMed ID: 19688145 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]